Patents by Inventor CIPLA Limited

CIPLA Limited has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Aerosol Composition
    Publication number: 20130160761
    Abstract: A pharmaceutical aerosol composition comprising at least one hydrofluoroalkane propellant; at least one active agent complexed with an adjuvant; and, optionally, at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: November 27, 2012
    Publication date: June 27, 2013
    Applicant: CIPLA LIMITED
    Inventors: CIPLA LIMITED, Mustafa Khwaja Hamieel
  • Process for the Preparation of Esomeprazole Magnesium Dihydrate
    Publication number: 20130150587
    Abstract: A process for preparing Form A of (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole magnesium dihydrate, processes for preparing various intermediates useful in the preparation of Form A of (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole magnesium dihydrate and a novel polymorphic Form II of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]thio]-1H-benzimidazole.
    Type: Application
    Filed: February 5, 2013
    Publication date: June 13, 2013
    Applicant: CIPLA LIMITED
    Inventor: CIPLA LIMITED
  • Pharmaceutical Combinations
    Publication number: 20130074834
    Abstract: A pharmaceutical combination comprising (a) a combination of two or more bronchodilators; or (b) a combination of at least one bronchodilator in combination with at least one corticosteroid.
    Type: Application
    Filed: November 21, 2012
    Publication date: March 28, 2013
    Applicant: CIPLA LIMITED
    Inventor: Cipla Limited
  • Combination of Azelastine and Mometasone for Nasal Administration
    Publication number: 20130029952
    Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
    Type: Application
    Filed: October 3, 2012
    Publication date: January 31, 2013
    Applicant: CIPLA LIMITED
    Inventor: CIPLA Limited
  • Combination of Azelastine and Ciclesonide for Nasal Administration
    Publication number: 20130029951
    Abstract: A pharmaceutical product or formulation, which comprises azelastine or a pharmaceutically acceptable salt, solvate or physiologically functional derivative thereof, and a steroid, or a pharmaceutical acceptable salt, solvate or physiologically functional derivative thereof, preferably the product or formulation being in a form suitable for nasal or ocular administration.
    Type: Application
    Filed: October 3, 2012
    Publication date: January 31, 2013
    Applicant: CIPLA LIMITED
    Inventor: CIPLA Limited